Acquired immunodeficiency syndrome related Kaposi's sarcoma eroding the maxillary bone

Journal of Laryngology and Otology

Volumn 122, Issue 9, 2008, Pages 993-997

  Konstantinopoulos, P A ^a   Goldsztein, H ^b   Dezube, B J ^a,d   Pantanowitz, L ^c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MARYLAND MEDICAL CENTER   (United States)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

AIDS; Kaposi's Sarcoma; Maxillary Bone

Indexed keywords

DOXORUBICIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; BIOPSY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CASE REPORT; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; ENDOSCOPY; HARD PALATE; HUMAN; INFECTION; KAPOSI SARCOMA; MALE; MAXILLA; MOLAR TOOTH; MOUTH LESION; MUCOSA INFLAMMATION; MULTIMODALITY CANCER THERAPY; ONCOLOGY; PNEUMOCYSTIS PNEUMONIA; RADIODIAGNOSIS; SOFT PALATE; SPHENOID SINUS; THRUSH; TOOTH EXTRACTION; TUMOR LOCALIZATION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; HUMANS; MALE; MAXILLA; MIDDLE AGED; PALATAL NEOPLASMS; PALATE, HARD; SARCOMA, KAPOSI;

EID: 50049120322     PISSN: 00222151     EISSN: 17485460     Source Type: Journal    
DOI: 10.1017/S0022215107008705     Document Type: Article

References (22)

1. Lorenzo GD, Konstantinopoulos PA, Pantanowitz L, Trollo RD, Placido SD, Dezube BJ. Management of AIDS-related Kaposi sarcoma: from conventional chemotherapy to molecularly targeted agents. Lancet Oncology 2007;8:167-76
2. Reichart PA, Gelderblom HR, Becker J, Kuntz A. AIDS and the oral cavity. The HIV-infection: virology, etiology, origin, immunology, precautions and clinical observations in 110 patients. Int J Oral Maxillofac Surg 1987;16:129-53
3. Schiodt M, Pindborg JJ. AIDS and the oral cavity. Epidemiology and clinical oral manifestations of human immune deficiency virus infection: a review. Int J Oral Maxillofac Surg 1987;16:1-14
4. Lausten LL, Ferguson BL, Barker BF, Cobb CM. Oral Kaposi sarcoma associated with severe alveolar bone loss: case report and review of the literature. J Periodontol 2003;74:1668-75
5. Kleinegger CL, Sarubin D. Intraoral Kaposi's sarcoma associated with alveolar bone erosion. Miss Dent Assoc J 1996;52:14-15
6. Langford A, Pohle HD, Reichart P. Primary intraosseous AIDS-associated Kaposi's sarcoma. Report of two cases with initial jaw involvement. Int J Oral Maxillofac Surg 1991;20:366-8
7. Nichols CM, Flaitz CM, Hicks MJ. Primary intraosseous Kaposi's sarcoma of the maxilla in human immunodeficiency virus infection: review of literature and report of case. J Oral Maxillofac Surg 1995;53:325-9
8. Righi P, Pierleoni L, Ficarra G. Bone involvement of the jaws in AIDS-related Kaposi's sarcoma. Minerva Stomatol 1994;43:521-4
9. Webster-Cyriaque J. Development of Kaposi's sarcoma in a surgical wound. N Engl J Med 2002;346:1207-10
10. De Pasquale R, Nasca MR, Micali G. Postirradiation primary Kaposi's sarcoma of the head and neck. J Am Acad Dermatol 1999;40:312-14
11. Glick M, Cleveland DB. Oral mucosal bacillary epithelioid angiomatosis in a patient with AIDS associated with rapid alveolar bone loss: case report. J Oral Pathol Med 1993;22:235-9
12. Restrepo CS, Martinez S, Lemos JA, Carrillo JA, Lemos DF, Ojeda P et al. Imaging manifestations of Kaposi sarcoma. Radiographics 2006;26:1169-85
13. Fliss DM, Parikh J, Freeman JL. AIDS-related Kaposi's sarcoma of the sphenoid sinus. J Otolaryngol 1992;21:235-7
14. Swift PS. The role of radiation therapy in the management of HIV-related Kaposi's sarcoma. Hematol Oncol Clin North Am 1996;10:1069-80
15. Gressen EL, Rosenstock JG, Xie Y, Corn BW. Palliative treatment of epidemic Kaposi sarcoma of the feet. Am J Clin Oncol 1999;22:286- 90
16. Ramirez-Amador V, Esquivel-Pedraza L, Lozada-Nur F, De la Rosa-Garcia E, Volkow-Fernandez P, Suchil-Bernal L et al. Intralesional vinblastine vs. 3% sodium tetradecyl sulfate for the treatment of oral Kaposi's sarcoma. A double blind, randomized clinical trial. Oral Oncol 2002;38:460-7
17. Gill PS, Wernz J, Scadden DT, Cohen P, Mukwaya GM, von Roenn JH et al. Randomized phase III trial of liposomal daunorubicin versus doxorubicin, bleomycin, and vincristine in AIDS-related Kaposi's sarcoma. J Clin Oncol 1996;14:2353-64
18. Northfelt DW, Dezube BJ, Thommes JA, Miller BJ, Fischl MA, Friedman-Kien A et al. Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin and vincristine treatment of AIDS-related Kaposi's sarcoma. Results of a randomized phase III clinical trial. J Clin Oncol 1998;16:2445-51
19. Krown SE. Highly active antiretroviral therapy in AIDS-associated Kaposi's sarcoma: implications for the design of therapeutic trials in patients with advanced, symptomatic Kaposi's sarcoma. J Clin Oncol 2004;22:399-402
20. Sgadari C, Barillari G, Toschi E, Carlei D, Bacigalupo I, Baccarini S et al. HIV protease inhibitors are potent antiangiogenic molecules and promote regression of Kaposi sarcoma. Nat Med 2002;8:225-32
21. Singh B, Har-el G, Lucente FE. Kaposi's sarcoma of the head and neck in patients with acquired immunodeficiency syndrome. Otolaryngol Head Neck Surg 1994;111:618-24
22. Epstein JB. Management of oral Kaposi's sarcoma and a proposal for clinical staging. Oral Dis 1997;3(suppl 1):S124-8